Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
6(50%)
Results Posted
100%(4 trials)

Phase Distribution

Ph phase_3
7
58%
Ph phase_1
1
8%
Ph phase_4
3
25%

Phase Distribution

1

Early Stage

0

Mid Stage

10

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 3Large-scale testing
7(63.6%)
Phase 4Post-market surveillance
3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

6

trials recruiting

Total Trials

12

all time

Status Distribution
Active(6)
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Recruiting5
Completed4
Withdrawn1
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
6
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (9.1%)
Phase 37 (63.6%)
Phase 43 (27.3%)

Trials by Status

withdrawn18%
recruiting542%
completed433%
active_not_recruiting18%
unknown18%

Recent Activity

6 active trials
Showing 5 of 12
recruitingphase_4

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

NCT06581328
active_not_recruitingphase_3

Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis

NCT03221036
recruitingphase_3

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

NCT06100289
recruitingphase_3

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

NCT05442567
recruitingphase_3

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

NCT04779320
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT06581328Phase 4

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

Recruiting
NCT03221036Phase 3

Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis

Active Not Recruiting
NCT06100289Phase 3

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Recruiting
NCT05442567Phase 3

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Recruiting
NCT04779320Phase 3

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Recruiting
NCT06856135

Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA

Unknown
NCT05837897Phase 3

A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease

Recruiting
NCT04804540Phase 4

A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease

Completed
NCT03029143Phase 4

Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis

Completed
NCT03234907Phase 3

Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.

Completed
NCT04469062Phase 3

A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis

Withdrawn
NCT02163421Phase 1

Bioavailability and Pharmacokinetics of Vedolizumab in Healthy Participants Following Single Subcutaneous Administration

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12